日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world efficacy and safety of Brolucizumab injection in vitrectomised eyes (BIVE) - a prospective multicentric study

Brolucizumab注射治疗玻璃体切除术后眼的真实世界疗效和安全性(BIVE)——一项前瞻性多中心研究

Boral, Subhendu Kumar; Agarwal, Deepak; Chakraborty, Debdulal; Das, Arnab; Sinha, Tushar Kanti

Expert Opinion on the First-Line Management of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in India: The Role of Faricimab

印度新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿一线治疗的专家意见:法瑞西单抗的作用

Jayadev, Chaitra; Talwar, Dinesh; Bhende, Muna; Narayanan, Raja; Gupta, Vishali; Chakraborty, Debdulal; Deka, Satyen; Manayath, George; Banker, Alay

High-efficacy and affordable hyperspectral pancreatic tissue image analysis using near-infrared spectroscopy

利用近红外光谱技术进行高效且经济实惠的胰腺组织高光谱图像分析

Tang, Zheng; Mishra, Abhinav; Mora, Benjamin; Al-Sarireh, Bilal; Irvine, Olivia; Mauri, Brandon; Higginbotham, Victoria; Bandaranayake, P M Anupama; Chandrashekhara, S H; Kanamarlapudi, Venkateswarlu; Roy, Debdulal

Zinc Complexes of Cationic Ammonium Phenyl and Methylpyridinium Porphyrins Display Synergistic Anti-HIV‑1 and Broad-Spectrum Antibacterial Activity.

阳离子铵苯基和甲基吡啶卟啉的锌配合物表现出协同抗HIV-1和广谱抗菌活性

Sharma Debdulal, Rai Madhu, Das Nandita, Kapavarapu Ravi Kumar, Pandey Piyush, Gaur Ritu, Sengupta Devashish

Pooled Multicenter Safety Analysis of Lupin's Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases

鲁宾公司玻璃体内注射生物类似药雷珠单抗(Ranieyes)治疗脉络膜视网膜血管疾病的多中心安全性汇总分析

Chakraborty, Debdulal; Sinha, Tushar Kanti; Sinha, Sourav; Maiti, Aniruddha; Mukherjee, Angshuman; Nandi, Krishnendu; Das, Sudipta; Majumdar, Saptorshi; Rungta, Dinesh; Bhattacharya, Ranabir

Safety and effectiveness of brolucizumab in patients with neovascular age-related macular degeneration: A phase IV study from India

印度一项IV期研究评估了brolucizumab治疗新生血管性年龄相关性黄斑变性患者的安全性和有效性。

Ghosh, Asim K; Chakraborty, Debdulal; Sudhalkar, Aditya; Chawla, Rohan; Singh, Simar R; Sahu, Atul K; Venkatesh, Ramesh; Raval, Vishal; Shah, Sonali; Preetha, Padma; Bhavsar, Maulik; Patil, Sandip; Khadke, Isha; Thorat, Anup

Authors' response: "Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group"

作者回复:“VRSI研究组关于印度患者使用Brolucizumab后出现眼内炎症的研究”

Agarwal, Manisha; Muralidhar, Alankrita; Chakraborty, Debdulal; Shanmugam, Mahesh P

Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG study

创新药雷珠单抗与生物类似药雷珠单抗联合膨胀性气体治疗黄斑下出血的比较:ICEBERG 研究

Chakraborty, Debdulal; Sinha, Tushar Kanti; Mondal, Soumen; Boral, Subhendu; Das, Arnab; Majumbar, Saptorshi; Mukherjee, Angshuman; Bhattacharya, Ranabir; Singh, Sumit Randhir

Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study

在印度真实世界中对法瑞西单抗治疗糖尿病性黄斑水肿进行临床评估——一项多中心观察性研究

Chakraborty, Debdulal; Das, Sudipta; Maiti, Aniruddha; Sinha, Tushar Kanti; Das, Arnab; Sheth, Jay; Boral, Subhendu Kumar; Mondal, Soumen; Nandi, Krishnendu

CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study

脉络膜视网膜血管疾病中创新药和生物类似药雷珠单抗的比较安全性分析——CRsIBS研究

Chakraborty, Debdulal; Sinha, Tushar Kanti; Sinha, Sourav; Biswas, Rupak Kanti; Maiti, Aniruddha; Boral, Subhendu; Das, Arnab; Mandal, Soumava; Bhattacharya, Ranabir; Dan, Shouvick; Rungta, Dinesh